Literature DB >> 26645423

Nasal and pharyngeal eosinophil peroxidase levels in adults with poorly controlled asthma correlate with sputum eosinophilia.

M A Rank1, S I Ochkur2, J C Lewis1, H G Teaford1, L J Wesselius2, R A Helmers3, N A Lee4, P Nair5, J J Lee2.   

Abstract

The objective of the study was to compare nasal, pharyngeal, and sputum eosinophil peroxidase (EPX) levels with induced sputum eosinophil percentage in 10 adults with poorly controlled asthma and 10 normal controls. EPX was measured using an ELISA and normalized for grams of protein for nasal and pharynx specimens and for mL-gram of protein for sputum. Sputum EPX levels were statistically different between asthma and control subjects (P = 0.024). EPX levels measured in the nasal and pharyngeal swab samples derived from the same patients were also different between asthma and control subjects, each displaying a high degree of significance (P = 0.002). Spearman's correlation coefficients for nasal EPX and pharyngeal EPX levels compared to induced sputum eosinophil percentage were 0.81 (P = 0.0007) and 0.78 (P = 0.0017), respectively. Thus, there is a strong association in a given patient between both nasal and pharyngeal EPX levels and the eosinophil percentage of induced sputum.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  asthma; diagnostics; eosinophil granule proteins; eosinophils; sputum

Mesh:

Substances:

Year:  2015        PMID: 26645423      PMCID: PMC4803514          DOI: 10.1111/all.12817

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  7 in total

1.  The development of a sensitive and specific ELISA for mouse eosinophil peroxidase: assessment of eosinophil degranulation ex vivo and in models of human disease.

Authors:  Sergei I Ochkur; John Dongil Kim; Cheryl A Protheroe; Dana Colbert; Redwan Moqbel; Paige Lacy; James J Lee; Nancy A Lee
Journal:  J Immunol Methods       Date:  2011-10-12       Impact factor: 2.303

2.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.

Authors:  Raed A Dweik; Peter B Boggs; Serpil C Erzurum; Charles G Irvin; Margaret W Leigh; Jon O Lundberg; Anna-Carin Olin; Alan L Plummer; D Robin Taylor
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

Review 3.  Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis.

Authors:  Daniël A Korevaar; Guus A Westerhof; Junfeng Wang; Jérémie F Cohen; René Spijker; Peter J Sterk; Elisabeth H Bel; Patrick M M Bossuyt
Journal:  Lancet Respir Med       Date:  2015-03-20       Impact factor: 30.700

4.  Development of the asthma control test: a survey for assessing asthma control.

Authors:  Robert A Nathan; Christine A Sorkness; Mark Kosinski; Michael Schatz; James T Li; Philip Marcus; John J Murray; Trudy B Pendergraft
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

Review 5.  Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.

Authors:  H L Petsky; J A Kynaston; C Turner; A M Li; C J Cates; T J Lasserson; A B Chang
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

6.  Nasal eosinophilia: an indicator of eosinophilic inflammation in asthma.

Authors:  M M Amorim; A Araruna; L B Caetano; A C Cruz; L L Santoro; A L G Fernandes
Journal:  Clin Exp Allergy       Date:  2010-01-20       Impact factor: 5.018

7.  Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia.

Authors:  P Nair; S I Ochkur; C Protheroe; K Radford; A Efthimiadis; N A Lee; J J Lee
Journal:  Allergy       Date:  2013-08-09       Impact factor: 13.146

  7 in total
  11 in total

1.  Epigenome-wide association study reveals methylation pathways associated with childhood allergic sensitization.

Authors:  Cheng Peng; Evelien R Van Meel; Andres Cardenas; Sheryl L Rifas-Shiman; Abhijeet R Sonawane; Kimberly R Glass; Diane R Gold; Thomas A Platts-Mills; Xihong Lin; Emily Oken; Marie-France Hivert; Andrea A Baccarelli; Nicolette W De Jong; Janine F Felix; Vincent W Jaddoe; Liesbeth Duijts; Augusto A Litonjua; Dawn L DeMeo
Journal:  Epigenetics       Date:  2019-03-28       Impact factor: 4.528

Review 2.  Eosinophilic and Noneosinophilic Asthma.

Authors:  Tara F Carr; Amir A Zeki; Monica Kraft
Journal:  Am J Respir Crit Care Med       Date:  2018-01-01       Impact factor: 21.405

3.  Allergic Endotypes and Phenotypes of Asthma.

Authors:  Nicole Akar-Ghibril; Thomas Casale; Adnan Custovic; Wanda Phipatanakul
Journal:  J Allergy Clin Immunol Pract       Date:  2020-02

Review 4.  Revisiting the NIH Taskforce on the Research needs of Eosinophil-Associated Diseases (RE-TREAD).

Authors:  Paneez Khoury; Praveen Akuthota; Steven J Ackerman; Joseph R Arron; Bruce S Bochner; Margaret H Collins; Jean-Emmanuel Kahn; Patricia C Fulkerson; Gerald J Gleich; Rashmi Gopal-Srivastava; Elizabeth A Jacobsen; Kristen M Leiferman; Levi-Schaffer Francesca; Sameer K Mathur; Michael Minnicozzi; Calman Prussin; Marc E Rothenberg; Florence Roufosse; Kathleen Sable; Dagmar Simon; Hans-Uwe Simon; Lisa A Spencer; Jonathan Steinfeld; Andrew J Wardlaw; Michael E Wechsler; Peter F Weller; Amy D Klion
Journal:  J Leukoc Biol       Date:  2018-04-19       Impact factor: 4.962

5.  Eosinophils and eosinophil-associated diseases: An update.

Authors:  Jeremy A O'Sullivan; Bruce S Bochner
Journal:  J Allergy Clin Immunol       Date:  2017-10-16       Impact factor: 10.793

Review 6.  Omalizumab for severe asthma: toward personalized treatment based on biomarker profile and clinical history.

Authors:  Farnaz Tabatabaian; Dennis K Ledford
Journal:  J Asthma Allergy       Date:  2018-04-03

7.  Normalized serum eosinophil peroxidase levels are inversely correlated with esophageal eosinophilia in eosinophilic esophagitis.

Authors:  B L Wright; S I Ochkur; N S Olson; K P Shim; E A Jacobsen; M A Rank; E S Dellon; J J Lee
Journal:  Dis Esophagus       Date:  2018-02-01       Impact factor: 3.429

8.  Eosinophil peroxidase over-expression predicts the clinical outcome of patients with primary lung adenocarcinoma.

Authors:  Liang Ye; Hongying Wang; Huijuan Li; Hongbing Liu; Tangfeng Lv; Yong Song; Fang Zhang
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

9.  Airway inflammatory profile among cleaning workers from different workplaces.

Authors:  Edinéia Rosa da Paz; Cynthia Mafra Fonseca de Lima; Soraia Nogueira Felix; Bruna Schaeffer; Clóvis Eduardo Santos Galvão; Aristides Tadeu Correia; Renato Fraga Righetti; Milton de Arruda Martins; Iolanda de Fátima Lopes Calvo Tibério; Beatriz Mangueira Saraiva-Romanholo
Journal:  BMC Pulm Med       Date:  2022-04-29       Impact factor: 3.320

10.  Biomarkers of Type 2 Airway Inflammation as Predictors of Loss of Asthma Control During Step-Down Therapy for Well-Controlled Disease: The Long-Acting Beta-Agonist Step-Down Study (LASST).

Authors:  Sonali Bose; Christian Bime; Robert J Henderson; Kathryn V Blake; Mario Castro; Emily DiMango; Nicola A Hanania; Janet T Holbrook; Charles G Irvin; Monica Kraft; Stephen P Peters; Joan Reibman; Elizabeth A Sugar; Kaharu Sumino; Robert A Wise; Linda Rogers
Journal:  J Allergy Clin Immunol Pract       Date:  2020-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.